Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence.

Wang Z, Lisowski L, Finegold MJ, Nakai H, Kay MA, Grompe M.

Mol Ther. 2012 Oct;20(10):1902-11. doi: 10.1038/mt.2012.157. Epub 2012 Sep 18.

2.

Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.

Chamberlain K, Riyad JM, Weber T.

Hum Gene Ther Methods. 2016 Feb;27(1):1-12. doi: 10.1089/hgtb.2015.140. Review.

3.

[Integration of AAV vectors and insertional mutagenesis].

Rossi A, Salvetti A.

Med Sci (Paris). 2016 Feb;32(2):167-74. doi: 10.1051/medsci/20163202010. Epub 2016 Mar 2. Review. French.

4.

Evaluation of risks related to the use of adeno-associated virus-based vectors.

Tenenbaum L, Lehtonen E, Monahan PE.

Curr Gene Ther. 2003 Dec;3(6):545-65. Review.

PMID:
14683451
5.

Integration of adeno-associated virus (AAV) and recombinant AAV vectors.

McCarty DM, Young SM Jr, Samulski RJ.

Annu Rev Genet. 2004;38:819-45. Review.

PMID:
15568995
6.

Adeno-associated virus vector integration.

Deyle DR, Russell DW.

Curr Opin Mol Ther. 2009 Aug;11(4):442-7. Review.

7.

Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.

High KA.

Trans Am Clin Climatol Assoc. 2003;114:337-51; discussion 351-2. Review.

8.

Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy.

Powell SK, Rivera-Soto R, Gray SJ.

Discov Med. 2015 Jan;19(102):49-57. Review.

Supplemental Content

Support Center